Skip to main content
Tuesday
September 23, 2025
Sign In
Subscribe
Latest
Economy
Banking
Stocks
Industry
Analysis
Bazaar
RMG
Corporates
Aviation
Videos
TBS Today
TBS Stories
TBS World
News of the day
TBS Programs
Podcast
Editor's Pick
World+Biz
Features
Panorama
The Big Picture
Pursuit
Habitat
Thoughts
Splash
Mode
Tech
Explorer
Brands
In Focus
Book Review
Earth
Food
Luxury
Wheels
Subscribe
Get the Paper
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Magazine
Climate Change
Health
Cartoons
বাংলা
TUESDAY,
SEPTEMBER 23, 2025
Johnson & Johnson Covid-19 Vaccine
Johnson & Johnson Covid-19 Vaccine
J & J expects up to $3.5 bln in Covid vaccine sales this year
Johnson booster 85% effective against Omicron: S Africa study
US CDC advisers to weigh limits on J&J vaccine due to blood clot issues -Washington Post
US brokers J&J-COVAX deal to send vaccines to conflict zones -Blinken
J&J says second shot boosts protection for moderate-severe Covid-19 to 94%
India set to get first J&J Covid vaccine doses in October, says source
Key data on US J&J, Moderna Covid-19 boosters weeks away, Fauci says
Second dose of J&J vaccine gives strong boost, says company report
South Africa study shows high Covid protection from J&J vaccine
Johnson & Johnson applies for approval of its single-dose Covid vaccine in India
J&J says still in talks with Indian govt on Covid-19 vaccine
J&J withdraws accelerated approval of its Covid vaccine in India
EU lists rare nerve disorder as side-effect of J&J Covid-19 vaccine
Show More